During this time period, Rite Aid's common stock will continue to be listed and will trade as usual. Rite Aid is in compliance with all other NYSE continued listing standard rules. Standley said the chain is following three paths toward its goal of "building a leader in health and wellness." It is serving as "the trusted advisor" for pharmacy customers, establishing "a winning value proposition for payers and providers," and becoming more of an omnichannel retailer to interact with customers and patients "where, when and how they want to shop." To boost the trust of patients, the chain is trying to redistribute workloads to free up pharmacists. One-trip refills consolidate work, while courtesy refills help Rite Aid predict when scripts will get filled and let it use central fill to take out rote labor "and allow our teams to try and spend more time interacting with our customers and patients to drive clinical outcomes," Standley said. "And that's really where we can create a lot of value."